EUVIMED · CrossrefZeitschrift
Frontiers in Drug Discovery
ISSN 2674-0338 · Frontiers Media SA
Neueste Artikel
FabI (enoyl-acyl carrier protein reductase): a key target for the development of antibacterial agents
Structure-based de novo design and computational prioritization of candidate allosteric smHDAC8 modulators: a fragment-based strategy against schistosomiasis
Benchmarking AI structure prediction tools for rational AAV vector engineering
Beyond membranes: the multifaceted mechanisms of antimicrobial peptides
Aqueous carbon dot-melatonin nanoassembly combined with Cu(II) for bactericidal and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa
Targeting histone lactylation in pancreatic ductal adenocarcinoma using RNA therapeutics: from metabolic-epigenetic mechanisms to clinical translation
Integrated virtual screening in discovering dual EGFR and Src inhibitor candidates
The highly G protein-biased mu opioid agonist displays buprenorphine-like efficacy in primates
Functional annotation of hypothetical proteins in Enterobacter cloacae 1382: investigating novel targets for antimicrobial resistance
Automation and machine learning in schistosomiasis drug discovery
Perspectives for building a computational drug discovery program in resource-limited settings
Palladium(II) aminoadamantane complexes: a promising approach to impair SARS-CoV-2 infection
Beyond BBB permeability: spatial and dynamic post-BBB barriers governing CNS drug action
Do property cliffs exist? A conceptual analysis of structural changes and molecular properties
A survey of LLMs in drug discovery and precision medicine
Editorial: Targeting cancer metabolic reprogramming for cancer therapy
Synthesis of copper oxide nanoparticles using Aloe vera leaf extract and their antibacterial activity against methicillin-resistant Staphylococcus aureus and multi-drug resistant Klebsiella pneumoniae
Spectral analysis and AI/ML-based data-driven approaches for enhanced protein conformation selection and prediction in drug discovery
Redefining the geography of pharmaceutical innovation: Kelly Chibale as a harbinger for integrated drug discovery in Africa
Correction: Fundamentals of dermatologic drug discovery
Minireview Kefir as a source of antimicrobial compounds against bacterial pathogens
Toward explainable and adaptive artificial intelligence systems for antimicrobial peptide discovery under resistance pressure
Modulating the human gut microbiome-host system: a new drug discovery paradigm
Fundamentals of dermatologic drug discovery
Computational screening of plant-derived compounds against SARS-CoV-2: methodological trends, limitations, and opportunities
Mapping the otoactive landscape: an LLM-aided extraction of compounds and their targets
Physical feasibility gating in early drug discovery: a decision framework for identifying predictable physical failures, with retrospective illustration
Electrophysiological mechanisms behind the differential cardiotoxicity of chemotherapeutic agents Bortezomib and Carfilzomib
Engineering hope: biomaterial strategies against glioblastoma
Role of angiotensin-converting enzyme in cognitive aging: evidence from preclinical and clinical studies
EUVIMED